SKI Market

A+| A| A-|

Indian Indices

Sensex

77,564.15 932.50
( 1.22%)

Global Indices

Nasdaq

48,208.69 277.76
(0.58%)

Dow Jones

6,845.97 42.16
(0.62%)

Hang Seng

56,916.27 1,020.95
(1.83%)

Nikkei 225

10,579.52 -29.36
(-0.28%)

Forex

USD-INR

92.44 -0.46
(-0.50%)

EUR-INR

107.96 0.52
(0.48%)

GBP-INR

124.05 0.88
(0.72%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aarey Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524412

INE198H01019

51.1335451

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AAREYDRUGS

54.28

186.23

EPS(TTM)

Face Value()

Div & Yield %

1.21

Back

Parsvnath Developers reports consolidated net loss of Rs 143.21 crore in the December 2025 quarter

Feb 12,2026

Net Loss of Parsvnath Developers reported to Rs 143.21 crore in the quarter ended December 2025 as against net loss of Rs 31.25 crore during the previous quarter ended December 2024. Sales rose 4.81% to Rs 61.04 crore in the quarter ended December 2025 as against Rs 58.24 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	61.04	58.24	5
OPM %	-6.59	12.43	-
PBDT	-126.12	-79.68	-58
PBT	-149.49	-93.09	-61
NP	-143.21	-31.25	-358

77,564.15 932.50 ( 1.22%)

48,208.69 277.76 (0.58%)

6,845.97 42.16 (0.62%)

56,916.27 1,020.95 (1.83%)

10,579.52 -29.36 (-0.28%)

92.44 -0.46 (-0.50%)

107.96 0.52 (0.48%)

124.05 0.88 (0.72%)

0.58 0.00 (0.32%)